Health Catalyst, Inc.

Annual Trend FY 2017 FY 2018 FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Depreciation and amortization $5.9m $7.4m $9.2m $18.7m $37.5m $48.3m $42.2m $41.4m $50.5m
Amortization of debt discount, issuance costs, and deferred financing costs $153k $533k $1.1m $8.1m $11.9m $1.5m $1.5m $3.3m $3.7m
Deferred tax provision $14k ($163k) $40k ($1.3m) ($7.1m) ($4.5m) $8k $77k $81k
Impairment of long-lived assets $0 $1.8m $5.0m $4.1m $2.2m $6.9m
Impairment of goodwill and intangible assets $0 $0 $110.2m
Non-cash operating lease expense $1.6m ($3.9m) $2.6m $4.3m $3.6m $3.2m $3.0m $2.7m $2.9m
Operating lease liabilities ($1.7m) $3.8m ($2.3m) ($3.4m) ($3.9m) ($3.5m) ($3.6m) ($3.5m) ($4.0m)
Operating lease right-of-use assets obtained in exchange for operating lease obligations $0 $6.6m $581k $24.5m $0 $169k $2.0m $1.3m $806k
Net loss ($47.0m) ($62.0m) ($60.1m) ($115.0m) ($153.2m) ($137.4m) ($118.1m) ($69.5m) ($178.0m)
Stock-based compensation expense $4.2m $4.2m $17.8m $38.0m $65.1m $72.1m $55.8m $40.1m $27.0m
Investment discount and premium accretion $72k ($143k) ($615k) $1.3m $1.2m ($2.2m) ($9.7m) ($4.8m) ($1.6m)
Provision for expected credit losses $359k $0 $863k $499k $691k $1.8m $1.2m $1.5m
Change in fair value of contingent consideration liabilities $0 $0 $14.1m $20.0m ($4.7m) $0 ($1.6m) ($7.1m)
Other $0 $0 ($15k) $116k ($53k) ($145k) $67k $141k ($429k)
Accounts receivable, net $4.4m ($3.6m) $127k ($16.4m) $102k $788k ($13.7m) $4.3m ($1.8m)
Prepaid expenses and other assets ($815k) ($1.3m) ($1.3m) ($3.7m) ($4.4m) ($478k) $164k ($50k) $1.6m
Accounts payable, accrued liabilities, and other liabilities ($6.3m) $4.6m ($86k) $8.2m $5.2m ($4.7m) $4.9m $5.6m ($11.5m)
Deferred revenue $2.1m $10.3m $77k $11.5m $7.6m ($6.0m) ($1.5m) ($7.0m) $607k
Capitalization of internal-use software ($197k) ($384k) ($1.4m) ($6.6m) ($13.0m) ($12.0m) ($14.3m) ($19.8m)
Purchases of property and equipment ($2.5m) ($2.3m) ($2.4m) ($7.8m) ($10.4m) ($2.2m) ($1.2m) ($1.6m) ($968k)
Purchases of intangible assets ($878k) ($228k) ($1.9m) ($1.2m) ($1.4m) ($2.3m) ($1.1m) ($508k) ($805k)
Proceeds from the sale of property and equipment $47k $29k $62k $14k $22k $29k $31k $13k $44k
Payment of deferred financing costs $0 $0 ($2.2m) $0
Proceeds from employee stock purchase plan $0 $0 $3.0m $4.3m $4.8m $3.2m $3.6m $2.4m $1.5m
Proceeds from exercise of stock options $76k $3.0m $2.7m $36.3m $20.4m $4.0m $950k $169k $0
Stock-based compensation capitalized as internal-use software $0 $0 $181k $636k $976k $889k $1.0m $1.0m
Capitalized internal-use software included in accounts payable and accrued liabilities $0 $0 $448k $169k $265k $189k
Purchase of property and equipment included in accounts payable and accrued liabilities $3k $84k $209k $2.3m $983k $213k $7k $13k $76k
Purchase of intangible assets included in accounts payable and accrued liabilities $675k $0 $1.6m $78k $520k $488k $1.3m $0 $1.7m
Net cash provided by (used in) operating activities ($36.8m) ($40.3m) ($32.2m) ($26.1m) ($23.1m) ($35.3m) ($33.1m) $14.6m $731k
Acquisition of businesses, net of cash acquired $0 $0 ($101.7m) ($46.8m) ($27.8m) ($11.4m) ($80.3m) ($41.1m)
Purchases of short-term investments ($46.4m) ($14.0m) ($256.0m) ($189.5m) ($261.4m) ($309.0m) ($290.8m) ($168.3m) ($65.1m)
Proceeds from the sale and maturity of short-term investments $72.1m $37.9m $50.7m $219.1m $186.9m $315.2m $336.8m $242.1m $163.9m
Net cash provided by (used in) investing activities $22.4m $21.4m ($209.6m) ($82.6m) ($139.7m) ($39.0m) $20.3m ($22.9m) $36.2m
Proceeds from issuance of long-term debt, net of issuance costs $0 $0 $152.3m $0
Repayment of debt $0 $0 ($959k) $232.3m
Common stock issued in connection with business acquisitions $0 $0 $72.5m $43.1m $3.0m $0 $24.9m $31.6m
Repurchase of common stock $0 ($8.7m) $0 $0 $0 ($8.4m) ($1.8m) $0 ($5.0m)
Net cash (used in) provided by financing activities $24.9m $24.3m $231.4m $182.6m $264.1m ($2.6m) $2.7m $151.7m ($235.8m)
Effect of exchange rate changes on cash and cash equivalents $0 $0 $6k $26k ($10k) ($11k) $21k ($34k) $27k
Net (decrease) increase in cash and cash equivalents $10.4m $5.5m ($10.4m) $73.9m $101.3m ($76.9m) ($10.0m) $143.4m ($198.8m)
Cash and cash equivalents at beginning of period $23.0m $28.4m $18.0m $92.0m $193.2m $116.3m $106.3m $249.6m $50.8m
Cash paid for interest $1.0m $3.9m $5.6m $5.0m $6.4m $5.8m $5.8m $10.1m $21.9m